Literature DB >> 10817069

A new visual indicator of chlamydial cervicitis?

J W Sellors1, S D Walter, M Howard.   

Abstract

OBJECTIVES: To determine the usefulness of endocervical discharge opacity as a risk indicator for chlamydial infection in relation to two acknowledged visual indicators--yellow endocervical discharge and easily induced mucosal bleeding of the cervix.
METHODS: Women from two family planning clinics, a therapeutic abortion clinic, and a university student health clinic (n = 1418 total) consented to a pelvic examination and chlamydia testing, and completed a questionnaire on socio-demographics, sexual behaviour, medical history, and symptoms. A case of chlamydia was defined as positive by culture or blocked enzyme immunoassay in an endocervical swab.
RESULTS: The prevalence of chlamydial infection in the clinics was 6.3%. All three of the visual indicators--yellow endocervical discharge, easily induced bleeding, and opaque cervical discharge--were statistically significantly and independently associated with chlamydial infection (odds ratios 2.8, 2.3, and 2.9 respectively), independent of clinic type. Adjustment for the other visual indicators made little difference to the odds ratios.
CONCLUSION: Opacity of endocervical discharge was at least as important as the other two commonly acknowledged indicators of chlamydial cervicitis--yellow endocervical discharge and easily induced mucosal bleeding of the cervix.

Entities:  

Mesh:

Year:  2000        PMID: 10817069      PMCID: PMC1760577          DOI: 10.1136/sti.76.1.46

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

1.  Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.

Authors:  J M Marrazzo; C L Celum; S D Hillis; D Fine; S DeLisle; H H Handsfield
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

2.  Chlamydia trachomatis infection in women attending urban midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques.

Authors:  D G Addiss; M L Vaughn; R Golubjatnikov; J Pfister; D F Kurtycz; J P Davis
Journal:  Sex Transm Dis       Date:  1990 Jul-Sep       Impact factor: 2.830

3.  Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis.

Authors:  J Sellors; M Howard; L Pickard; D Jang; J Mahony; M Chernesky
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

4.  Clinical predictors of Chlamydia trachomatis endocervicitis in adolescent women. Looking for the right combination.

Authors:  G Remafedi; S E Abdalian
Journal:  Am J Dis Child       Date:  1989-12

5.  Clinical characteristics of women with chlamydial cervicitis.

Authors:  L E Lindner; S Geerling; J A Nettum; S L Miller; K H Altman
Journal:  J Reprod Med       Date:  1988-08       Impact factor: 0.142

6.  Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men.

Authors:  R C Brunham; J Paavonen; C E Stevens; N Kiviat; C C Kuo; C W Critchlow; K K Holmes
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

7.  Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women.

Authors:  J W Sellors; L Pickard; A Gafni; C H Goldsmith; D Jang; J B Mahony; M A Chernesky
Journal:  Arch Intern Med       Date:  1992-09

8.  Chlamydial cervical infection in jailed women.

Authors:  M D Holmes; S M Safyer; N A Bickell; S H Vermund; P A Hanff; R S Phillips
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

9.  Selective screening for Chlamydia trachomatis infection in a primary care population of women.

Authors:  A Stergachis; D Scholes; F E Heidrich; D M Sherer; K K Holmes; W E Stamm
Journal:  Am J Epidemiol       Date:  1993-08-01       Impact factor: 4.897

Review 10.  Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.